{
  "url": "https://openlegislation.uk/draft-infected-blood-compensation-scheme-regulations-2025/schedule-2/paragraph-7",
  "json_url": "https://openlegislation.uk/draft-infected-blood-compensation-scheme-regulations-2025/schedule-2/paragraph-7.json",
  "legislation": "ukdsi/2025/9780348268843",
  "legislation_title": "The Infected Blood Compensation Scheme Regulations 2025",
  "legislation_url": "https://openlegislation.uk/draft-infected-blood-compensation-scheme-regulations-2025",
  "path": "schedule/2/paragraph/7",
  "kind": "paragraph",
  "number": "7",
  "heading": "Hepatitis-associated conditions resulting in long-term severe disability",
  "text": "(1) A person (“P”) is to be treated as having a Hepatitis-associated condition resulting in long-term severe disability if P—\n(a) has a Hepatitis B infection of severity level 2, 3 or 4 and P has been diagnosed with any of the conditions listed in sub-paragraph (2);\n(b) has a Hepatitis C infection of severity level 2, 3 or 4 and—\n(i) P has been diagnosed with any of the conditions listed in sub-paragraph (3), and\n(ii) in the case of a condition listed in sub-paragraph (3)(a) to (c), the condition was caused or exacerbated by interferon treatment for Hepatitis C.\n(2) The conditions referred to in sub-paragraph (1)(a) are—\n(a) Coombs positive haemolytic anaemia caused or exacerbated by interferon treatment for Hepatitis B;\n(b) idiopathic fibrosing alveolitis of the lung caused or exacerbated by interferon treatment for Hepatitis B;\n(c) rheumatoid arthritis that is either related directly to Hepatitis B or caused or exacerbated by interferon treatment for Hepatitis B;\n(d) aplastic anaemia.\n(3) The conditions referred to in sub-paragraph (1)(b)(i) are—\n(a) Coombs positive haemolytic anaemia;\n(b) idiopathic fibrosing alveolitis of the lung;\n(c) rheumatoid arthritis;\n(d) sporadic porphyria cutanea tarda causing photosensitivity with blistering;\n(e) immune thrombocytopenic purpura;\n(f) type 2 or 3 mixed cryoglobulinaemia accompanied by—\n(i) cerebral vasculitis,\n(ii) dermal vasculitis, or\n(iii) peripheral neuropathy with neuropathic pain.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2025/9780348268843/schedule/2/paragraph/7",
    "retrieved_at": "2026-10-30T14:39:35.762697+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}